期刊文献+

多烯磷脂酰胆碱联合复方甘草酸苷治疗酒精性肝病的疗效观察 被引量:2

Effect of polyene phosphatidyl choline combined with compound glycyrrhizin in treatment of alcoholic liver disease
原文传递
导出
摘要 目的观察多烯磷脂酰胆碱联合复方甘草酸苷治疗酒精性肝病的疗效和安全性。方法将72例酒精性肝病患者随机分为两组,对照组36例给予复方甘草酸苷治疗,治疗组36例在对照组治疗的基础上应用多烯磷脂酰胆碱治疗,疗程均为4周,观察治疗前后症状、体征和肝功能的变化,并监测药物不良反应。结果治疗组的显效率和总有效率显著高于对照组(χ^2=4.1806,P〈0.05),治疗后两组患者天门冬氨酸氨基转移酶、丙氨酸氨基转移酶、碱性磷酸酶、γ-谷氨酰基转肽酶和总胆红素均较治疗前明显降低(P均〈0.01),且治疗组天门冬氨酸氨基转移酶、丙氨酸氨基转移酶、谷氨酰转移酶、γ-谷氨酰基转肽酶和总胆红素下降程度均显著优于对照组(t=10.589,6.8388,3.4320,3.9504,4.2626,P均〈0.01)。两组均未见明显不良反应。结论多烯磷脂酰胆碱联合复方甘草酸苷治疗酒精性肝病安全有效,优于单用复方甘草酸苷。 Objective To observe the effect and safety of polyene phosphatidyl choline combined with compound glycyrrhizin in treatment of alcoholic liver disease. Methods Seventy-two patients with alcoholic liver disease were randomly divided into two groups, 36 cases in the control group received compound giycyrrhizin therapy, 36 cases in the treatment group received polyene phosphatidyl choline on the basis of the control group. The treatment lasted four weeks in the two groups. To observe the changes in symptoms, signs and liver function( AST, ALT, GGT, ALP, TBiL) of patients in the two groups beforeand after treatment. And to monitor adverse drug reactions. Results Apparent efficiency and total efficiency rate of the treatment group was significantly higher than that of the control group ( χ^2 = 4,4. 1806, P 〈 0.05 ). After treatment, AST, ALT , GGT, ALP and TBiL of patients in the two groups were significantly lower than those before treatment ( P all 〈 0.01 ). And AST, ALT, GGT, ALP and TBiL of patients in treatment group were significantly better than those in the control group (t = 10. 589,6. 8388,3. 4320,3.9504,4. 2626, P 〈 0.01 ). Conclusions Polyene phosphatidyl choline combined with compound glycyrrhizin in treatment of alcoholic liver disease is safe and effective, is better than treat with single compound glycyrrhizin.
作者 王瑞雪
出处 《中国实用医刊》 2013年第5期55-57,共3页 Chinese Journal of Practical Medicine
关键词 多烯磷脂酰胆碱 复方甘草酸苷 酒精性肝病 Polyene phosphatidyl choline Compound glycyrrhizin Alcoholic liver disease
  • 相关文献

参考文献12

二级参考文献62

共引文献431

同被引文献26

  • 1孙菲菲,韩明子,金世柱,方泰石,姚国栋,许军.不同剂量还原型谷胱甘肽对大鼠急性肝损伤的修复作用[J].胃肠病学和肝病学杂志,2009,18(11):1037-1039. 被引量:5
  • 2陈小囡,朱晞,方志明,俞利平.丹参注射液对大鼠酒精性肝损伤血清IL-8值的影响[J].中国中医基础医学杂志,2005,11(4):290-291. 被引量:13
  • 3陈昭英.还原型谷胱甘肽治疗药物性肝损害的临床研究[J].中国基层医药,2005,12(12):1762-1762. 被引量:2
  • 4张帆,朱文莲,张亚东.还原型谷胱甘肽治疗酒精性肝硬化临床观察[J].河南科技大学学报(医学版),2006,24(2):110-111. 被引量:4
  • 5Frazier T H, Stocker A M, Kershner N A, et al. Treatment of alcoholic liver disease [J ]. Therap Adv Gastroenterol, 2011, 4(1): 63.
  • 6Caputo F, Bemardi M, Zoli G. Efficacy and safety of γ - hy- droxybutyrate in treating alcohol withdrawal syndrome in an alcohol- dependent inpatient with decompensated liver cir- rhosis: a case report[J]. J Clin Psyehopharrnacol, 2011, 31 (1): 140.
  • 7Yang H Y, Lin H S, Chao J C, et al. Effects of soy protein on alcoholic liver disease in rats undergoing ethanol withdraw- al[J]. J Nutr Biochem, 2012, 23(6) : 679.
  • 8Trabut J B, Thepot V, Nalpas B, et al. Rapid decline of liv- er stiffness following alcohol withdrawal in heavy drinkers [J]. Alcohol Clin Exp Re.s, 2012, 36(8) : 1407.
  • 9Leggio L, Kenna G A, Ferrulli A, et al. Preliminary find- ings on the use of metadoxine for the treatmem of alcohol de- pendence andalcoholic liver disease[J]. Hum Psychopharma- col, 2011, 26(8): 554.
  • 10Mao Y M, Zeng M D, Li Y M, et al. Capsule metadoxine in the treatment of alcoholic liver disease: a randomized, double - blind, placebo - controlled, multicenter study [ J ]. Zhonghua Gan Zang Bing Za Zhi, 2009, 17(3) : 213.

引证文献2

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部